Workflow
WSJ
icon
Search documents
Dollarama Lifts Outlook as Canadian Shoppers Boost Results
WSJ· 2025-12-11 18:02
Robust consumer demand drove higher traffic and spending across stores at Canada's largest dollar-store chain. ...
Palantir Sues CEO of Rival AI Firm, Alleges Widespread Effort to Poach Employees
WSJ· 2025-12-11 16:06
Lawsuit says Percepta's chief executive built a "copycat†company after leaving Palantir last year ...
U.S. Trade Deficit Fell to 5-Year Low in September
WSJ· 2025-12-11 13:59
The U.S. trade deficit decreased in September, declining to the lowest level in five years as trade patterns adjust to the steep new tariffs levied by President Trump. ...
Jobless Claims Rose Last Week But Remained Modest
WSJ· 2025-12-11 13:56
The number of Americans filing new claims for unemployment benefits rose last week but stayed well within the range that has prevailed over the past year. ...
OPEC Holds Oil-Demand View Steady But Expects Higher Supply From Rivals
WSJ· 2025-12-11 13:09
Core Viewpoint - The Organization of the Petroleum Exporting Countries (OPEC) has maintained its oil-demand outlook while preparing to pause output increases in early 2026, but has slightly raised its supply forecast for this year [1] Group 1: Oil Demand Outlook - OPEC has left its oil-demand outlook unchanged, indicating stability in expected consumption levels [1] - The decision reflects confidence in the current market dynamics and demand trends [1] Group 2: Supply Forecast - OPEC has modestly increased its forecast for oil supply for the current year, suggesting a response to market conditions [1] - This adjustment may indicate an anticipation of higher production levels to meet demand [1] Group 3: Output Policy - The organization is preparing to pause output hikes in early 2026, signaling a strategic approach to managing production levels [1] - This pause may be aimed at balancing supply and demand in the oil market [1]
Eli Lilly Reports Positive Results From Study of Weight Loss Drug
WSJ· 2025-12-11 12:54
Core Insights - Eli Lilly's experimental weight-loss drug retatrutide has shown significant efficacy in reducing weight and alleviating knee pain in a phase three trial involving patients suffering from obesity and knee osteoarthritis [1] Group 1 - The phase three trial demonstrated that retatrutide resulted in substantial weight loss among participants [1] - Patients reported a reduction in knee pain, indicating potential benefits for those with knee osteoarthritis [1]
Altria CEO Gifford to Retire in 2026, CFO Mancuso Tapped to Take Over
WSJ· 2025-12-11 12:28
Core Viewpoint - Altria Group announced the retirement of Chief Executive Billy Gifford, effective May, and appointed Chief Financial Officer Sal Mancuso as his successor [1] Company Summary - Billy Gifford will retire in May, marking a significant leadership change for Altria Group [1] - Sal Mancuso, currently the Chief Financial Officer, has been named as the new CEO [1]
Oracle Can't Escape OpenAI's Shadow
WSJ· 2025-12-11 10:30
Core Insights - The parent company of ChatGPT continues to represent the majority of the software company's revenue backlog [1] Group 1 - The software company relies heavily on the revenue generated from its ChatGPT product, indicating its significance in the overall financial performance [1]
Global Markets Fall as Oracle Selloff Drags Tech Stocks
WSJ· 2025-12-11 09:26
Core Insights - A decline in Oracle's shares has shifted investor attention towards the sustainability of the AI-driven market boom, negatively impacting markets in Asia and Europe [1] Company Impact - Oracle's share slump has raised concerns about the long-term viability of the AI-led growth trend [1] Market Reaction - The downturn in Oracle's stock has contributed to a broader decline in market performance across Asia and Europe [1]